Literature DB >> 32070768

Downregulation of Lnc-OC1 attenuates the pathogenesis of polycystic ovary syndrome.

Gengxiang Wu1, Zhe Yang1, Yajie Chen1, Xiaoling Li1, Jing Yang2, Tailang Yin3.   

Abstract

Long non-coding RNAs (lncRNAs) play a vital role in the progression of many human diseases. The aim of this study is to explore the relationship between lncRNA-ovarian cancer associated 1 (Lnc-OC1) and PCOS. In this study, we found that Lnc-OC1 was significantly higher in PCOS granulosa cells (GCs) compared to non-PCOS GCs. Lnc-OC1 knockdown inhibited cell viability and promoted cell apoptosis, expression of aromatase mRNA and production of estradiol in KGN cells. In PCOS mice, Lnc-OC1 promoted the serum insulin release, production of angiogenesis-related factors and IκBα phosphorylation, which could be partially restored by Lnc-OC1 shRNA. These results suggest that Lnc-OC1 plays an important part in the pathogenesis of PCOS.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Granulosa cells; Polycystic ovary syndrome; lnc-OC1

Mesh:

Substances:

Year:  2020        PMID: 32070768     DOI: 10.1016/j.mce.2020.110760

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  3 in total

1.  Novel Hub genes co-expression network mediates dysfunction in a model of polycystic ovary syndrome.

Authors:  Sujuan Xi; Weihao Li; Zaiyi Li; Wenjing Lin; Lin Chen; Chengzi Tian; Yazhu Yang; Lin Ma
Journal:  Am J Transl Res       Date:  2022-03-15       Impact factor: 4.060

Review 2.  microRNAs and long non-coding RNAs as biomarkers for polycystic ovary syndrome.

Authors:  Mona Tamaddon; Mostafa Azimzadeh; Seyed Mohammad Tavangar
Journal:  J Cell Mol Med       Date:  2022-01-06       Impact factor: 5.310

3.  LncRNA LNCOC1 is Upregulated in Melanoma and Serves as a Potential Regulatory Target of miR-124 to Suppress Cancer Cell Invasion and Migration.

Authors:  Changhai Liu; Xiangsheng Ding; Cuie Wei; Yongdong Pei; Fanjun Meng; Yuren Zhong; Yi Liu
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-04-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.